EASD: Intensive Glucose Control Cuts Renal Risks - MedPage Today PDF Print
MedPage Today
LISBON -- Intensive glucose-lowering may protect against end-stage renal disease (ESRD) in diabetic patients, according to an analysis of data from the ADVANCE trial. Over a mean follow up of five years,

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.